文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

呼吸力学指导的镇静策略对慢性阻塞性肺疾病机械通气患者膈肌功能的影响

[Effect of respiratory mechanics-guided sedation strategy on diaphragm function in mechanical ventilated patients with chronic obstructive pulmonary disease].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论对AECOPD机械通气患者,呼吸力学指导的镇静策略可降低膈肌快速浅呼吸指数、提高膈肌位移效率并缩短机械通气时间。

前瞻性研究纳入2020年5月至2021年5月济宁医学院附属湖西医院收治的AECOPD有创机械通气患者96例,排除6例后最终90例,观察组46例、对照组44例。观察组每6小时监测呼吸力学,按气道阻力(Raw)>20 cmH2O×L-1×s-1时深镇静维持RASS≤-3、Raw 10-20 cmH2O×L-1×s-1时维持RASS -2-0、Raw<10 cmH2O×L-1×s-1时撤除镇静或浅镇静维持RASS -2-0调整镇静深度;对照组给予浅镇静。结果显示观察组治疗3天和5天D-RSBI低于对照组、DEE高于对照组,两组DE无显著差异;观察组机械通气时间短于对照组,28天死亡率无显著差异。

要点

  • 观察组按Raw分层调整镇静:Raw>20 cmH2O×L-1×s-1时深镇静维持RASS≤-3,Raw 10-20 cmH2O×L-1×s-1时维持RASS -2-0,Raw<10 cmH2O×L-1×s-1时撤除镇静或浅镇静维持RASS -2-0。
  • 观察组治疗3天D-RSBI 1.73±0.48 vs 对照组1.96±0.35(次×min-1×mm-1),5天1.45±0.64 vs 1.72±0.40,均P<0.05。
  • 观察组治疗3天DEE 19.7±4.3 vs 对照组17.1±3.9(mL/mm),5天25.8±5.6 vs 22.9±5.4,均P<0.05;两组各时间点DE无显著差异。
  • 观察组机械通气时间5.78±2.01天 vs 对照组6.84±2.27天(P<0.05);28天死亡率观察组2.2% vs 对照组2.3%(P>0.05)。
  • 镇静后2小时内RASS评分观察组第1天-3.78±0.92 vs 对照组-2.34±0.68、第2天-2.87±1.04 vs -2.43±0.79(均P<0.05),第3天两组无统计学差异。

适用人群与场景

  • 2020年5月至2021年5月济宁医学院附属湖西医院收治的AECOPD接受有创机械通气患者。
  • 排除因谵妄或机械通气时间短于3天者6例,最终纳入90例(观察组46例、对照组44例)。

诊断标准与关键阈值

  • 观察组每6小时监测呼吸力学,按气道阻力(Raw)调整镇静深度:Raw>20 cmH2O×L-1×s-1时深镇静维持RASS≤-3;Raw 10-20 cmH2O×L-1×s-1时初始镇静深度维持RASS -2-0;Raw<10 cmH2O×L-1×s-1时撤除镇静或浅镇静维持RASS -2-0。
  • 对照组给予浅镇静。
  • 膈肌快速浅呼吸指数D-RSBI=呼吸频率/膈肌位移(RR/DE),膈肌位移效率DEE=潮气量/膈肌位移(VT/DE)。

处置流程与药物剂量

  • 两组均气管插管机械通气,并给予支气管扩张剂、糖皮质激素、抗感染、祛痰、营养支持、镇痛镇静。
  • 两组镇静药为右美托咪定联合丙泊酚,镇痛药为舒芬太尼。
  • 观察组每6小时行呼吸力学监测,并按Raw分层调整镇静深度(Raw>20 cmH2O×L-1×s-1时深镇静维持RASS≤-3;Raw 10-20 cmH2O×L-1×s-1时维持RASS -2-0;Raw<10 cmH2O×L-1×s-1时撤除镇静或浅镇静维持RASS -2-0)。
  • 对照组给予浅镇静。
  • 床旁超声测量膈肌位移(DE),记录潮气量(VT)和呼吸频率(RR),计算D-RSBI和DEE。

红旗征与不能漏的情况

  • 谵妄或机械通气时间短于3天者被排除。

研究设计与关键结果

  • 前瞻性研究,最终纳入90例AECOPD机械通气患者,观察组46例、对照组44例;两组治疗前DE、D-RSBI、DEE无统计学显著差异。
  • 治疗后两组D-RSBI随时间逐渐降低、DEE随时间逐渐升高;观察组治疗3天D-RSBI 1.73±0.48 vs 对照组1.96±0.35(次×min-1×mm-1),5天1.45±0.64 vs 1.72±0.40,均P<0.05。
  • 观察组治疗3天DEE 19.7±4.3 vs 对照组17.1±3.9(mL/mm),5天25.8±5.6 vs 22.9±5.4,均P<0.05;两组各时间点DE无显著差异。
  • 镇静后2小时内RASS评分观察组第1天-3.78±0.92 vs 对照组-2.34±0.68、第2天-2.87±1.04 vs -2.43±0.79(均P<0.05),第3天两组无统计学差异。
  • 观察组机械通气时间5.78±2.01天 vs 对照组6.84±2.27天(P<0.05);28天死亡率观察组2.2% vs 对照组2.3%(P>0.05)。

证据类型、等级与局限

  • 证据类型:前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对AECOPD机械通气患者,呼吸力学指导的镇静策略可降低D-RSBI、提高DEE、缩短机械通气时间,对膈肌有一定保护作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effects of respiratory mechanics-guided sedation strategy on diaphragm function in chronic obstructive pulmonary disease (COPD) patients treated with mechanical ventilation (MV).

METHODS: A prospective study was conducted. Patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) received invasive MV who were admitted to the Affiliated Huxi Hospital of Jining Medical University from May 2020 to May 2021 were enrolled. The patients were divided into observational group and control group by random number table method. All patients were intubated for MV, and received bronchodilators, glucocorticoid, anti-infectives, expectorant, nutritional support, analgesia and sedation. The sedatives were dexmedetomidine combined with propofol, and the analgesics were sufentanil in both groups. Respiratory mechanics monitoring was performed every 6 hours in the observational group, and the depth of sedation was adjusted according to the parameters of respiratory mechanics: when airway resistance (Raw) > 20 cmH2O×L-1×s-1, deep sedation was given to maintain Richmond agitation-sedation scale (RASS) ≤ -3; when the Raw was 10-20 cmH2O×L-1×s-1, the initial depth of sedation maintained to reach the RASS score of -2-0; when Raw < 10 cmH2O×L-1×s-1, withdrawn the sedation, or given light sedation, and maintained the RASS score of -2-0. While the control group received light sedation. The patients' diaphragmatic excursions (DE) was measured by bedside ultrasound, tidal volume (VT) and respiratory rate (RR) were recorded, and the diaphragmatic rapid shallow breathing index (D-RSBI, D-RSBI = RR/DE) and diaphragmatic excursion efficiency (DEE, DEE = VT/DE) were calculated. The differences in DE, D-RSBI, and DEE before and 3 days and 5 days of treatment between the two groups were compared. The difference in the RASS score within 3 days of sedation between the two groups was compared. The differences in the duration of MV and 28-day mortality between the two groups were compared.

RESULTS: A total of 96 patients were selected. Six patients were excluded due to delirium or the duration of MV shorter than 3 days. Finally, 90 patients were enrolled, with 46 in the observational group, and 44 in the control group. There were no statistically significant differences in DE, D-RSBI or DEE before treatment between the two groups. After treatment, D-RSBI in both groups was gradually decreased, and DEE was gradually increased with time. The D-RSBI at 3 days and 5 days of treatment in the observational group were significantly lower than those in the control group (times×min-1×mm-1: 1.73±0.48 vs. 1.96±0.35 at 3 days, 1.45±0.64 vs. 1.72±0.40 at 5 days, both P < 0.05), and DEE were significantly higher than those in the control group (mL/mm: 19.7±4.3 vs. 17.1±3.9 at 3 days, 25.8±5.6 vs. 22.9±5.4 at 5 days, both P < 0.05). There was no significant difference in DE at all time points between the two groups. The RASS scores within 2 hours of sedation in the observational group were significantly lower than those in the control group (1 day: -3.78±0.92 vs. -2.34±0.68, 2 days: -2.87±1.04 vs. -2.43±0.79, both P < 0.05), while no statistical difference at 3 days was found between the two groups. The duration of MV in the observational group was significantly shorter than that in the control group (days: 5.78±2.01 vs. 6.84±2.27, P < 0.05). One patient died in each of the control group and the observational group, and there was no significant difference in the 28-day mortality between the two groups (2.3% vs. 2.2%, P > 0.05).

CONCLUSIONS: For AECOPD patients undergoing MV, respiratory mechanics-guided sedation strategy can reduce D-RSBI, increase DEE, shorten the duration of MV, and have a certain protective effect on the diaphragm.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu Z, Meng S, Wu Y, et al. [Effect of respiratory mechanics-guided sedation strategy on diaphragm function in mechanical ventilated patients with chronic obstructive pulmonary disease]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36100406. doi:10.3760/cma.j.cn121430-20210816-01187

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。